Viewing Study NCT02874651

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-03-07 @ 7:05 PM
Study NCT ID: NCT02874651
Status: TERMINATED
Last Update Posted: 2022-01-11
First Post: 2016-08-01
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy
Sponsor: Sun Yat-sen University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Nasopharyngeal Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Nasopharyngeal Carcinoma View
None EB Virus View
None DNA View
None vascular endothecial growth factor receptor inhibitor View
None Apatinib View